A carregar...
Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases
The treatment of metastatic castrate-resistant prostate cancer (mCRPC) has grown over the past decade. The majority of patients develop bone metastases, which pose a significant burden on morbidity and mortality, especially skeletal-related events. Whilst demonstrating a favourable safety profile an...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872188/ https://ncbi.nlm.nih.gov/pubmed/27247627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287216629870 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|